Fauci Says Delta COVID-19 Variant Is Greatest Threat to US Pandemic Response

Reuters  |

Video source: YouTube, NBC News

By Carl O'Donnell

June 22 (Reuters) - The Delta variant of the novel coronavirus that was first found in India is the greatest threat to the United States’ effort to eradicate COVID-19 in its borders, said U.S. infectious disease expert Dr. Anthony Fauci during a Tuesday press call.

"The transmissibility is unquestionably greater" in the Delta variant than the original variant of COVID-19, Fauci said, adding that "it is associated with an increased disease severity."

The Delta variant is becoming the globally dominant version of the disease, the World Health Organization's chief scientist said on Friday.

Fauci said that the vaccines authorized in the United States, including the Pfizer/BioNTech vaccine, are effective against the new variant of COVID-19.

"We have the tools, so let's use them and crush the outbreak," Fauci said.

The United States is falling short of its goal of vaccinating 70% of adults by July 4 and will likely need a few additional weeks to hit that target, White House COVID-19 senior adviser Jeffrey Zients said during the press call.

Betting Against Elon Musk Has Not Been Profitable

Zients added that he expects 70% of adults over 27 years old will have had at least one shot by July 4.

More than 150 million people in the United States, or more than 45% of the population, have been fully vaccinated, according to federal data last updated on Monday.

The Delta variant contributed to a severe outbreak of COVID-19 in India during April and May that overwhelmed health services in the country and killed hundreds of thousands.

Reporting by Carl O'Donnell Editing by Chris Reese.

_____

Source: Reuters, NBC News

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content